Literature DB >> 23833192

The RNA-binding protein fused in sarcoma (FUS) functions downstream of poly(ADP-ribose) polymerase (PARP) in response to DNA damage.

Adam S Mastrocola1, Sang Hwa Kim, Anthony T Trinh, Lance A Rodenkirch, Randal S Tibbetts.   

Abstract

The list of factors that participate in the DNA damage response to maintain genomic stability has expanded significantly to include a role for proteins involved in RNA processing. Here, we provide evidence that the RNA-binding protein fused in sarcoma/translocated in liposarcoma (FUS) is a novel component of the DNA damage response. We demonstrate that FUS is rapidly recruited to sites of laser-induced DNA double-strand breaks (DSBs) in a manner that requires poly(ADP-ribose) (PAR) polymerase activity, but is independent of ataxia-telangiectasia mutated kinase function. FUS recruitment is mediated by the arginine/glycine-rich domains, which interact directly with PAR. In addition, we identify a role for the prion-like domain in promoting accumulation of FUS at sites of DNA damage. Finally, depletion of FUS diminished DSB repair through both homologous recombination and nonhomologous end-joining, implicating FUS as an upstream participant in both pathways. These results identify FUS as a new factor in the immediate response to DSBs that functions downstream of PAR polymerase to preserve genomic integrity.

Entities:  

Keywords:  ATM; DNA Damage Response; DNA Repair; Fused in Sarcoma; Homologous Recombination; PARP; RNA-binding Proteins; Radiation Biology

Mesh:

Substances:

Year:  2013        PMID: 23833192      PMCID: PMC3750169          DOI: 10.1074/jbc.M113.497974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins.

Authors:  Carsten Doil; Niels Mailand; Simon Bekker-Jensen; Patrice Menard; Dorthe Helena Larsen; Rainer Pepperkok; Jan Ellenberg; Stephanie Panier; Daniel Durocher; Jiri Bartek; Jiri Lukas; Claudia Lukas
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

Review 2.  The DNA-damage response in human biology and disease.

Authors:  Stephen P Jackson; Jiri Bartek
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

Review 3.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

4.  The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.

Authors:  Grant S Stewart; Stephanie Panier; Kelly Townsend; Abdallah K Al-Hakim; Nadine K Kolas; Edward S Miller; Shinichiro Nakada; Jarkko Ylanko; Signe Olivarius; Megan Mendez; Ceri Oldreive; Jan Wildenhain; Andrea Tagliaferro; Laurence Pelletier; Nadine Taubenheim; Anne Durandy; Philip J Byrd; Tatjana Stankovic; A Malcolm R Taylor; Daniel Durocher
Journal:  Cell       Date:  2009-02-06       Impact factor: 41.582

5.  Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

Authors:  T J Kwiatkowski; D A Bosco; A L Leclerc; E Tamrazian; C R Vanderburg; C Russ; A Davis; J Gilchrist; E J Kasarskis; T Munsat; P Valdmanis; G A Rouleau; B A Hosler; P Cortelli; P J de Jong; Y Yoshinaga; J L Haines; M A Pericak-Vance; J Yan; N Ticozzi; T Siddique; D McKenna-Yasek; P C Sapp; H R Horvitz; J E Landers; R H Brown
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

6.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining.

Authors:  Kyle M Miller; Jorrit V Tjeertes; Julia Coates; Gaëlle Legube; Sophie E Polo; Sébastien Britton; Stephen P Jackson
Journal:  Nat Struct Mol Biol       Date:  2010-08-29       Impact factor: 15.369

7.  High-resolution profiling of gammaH2AX around DNA double strand breaks in the mammalian genome.

Authors:  Jason S Iacovoni; Pierre Caron; Imen Lassadi; Estelle Nicolas; Laurent Massip; Didier Trouche; Gaëlle Legube
Journal:  EMBO J       Date:  2010-04-01       Impact factor: 14.012

8.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

9.  Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.

Authors:  Yaron Galanty; Rimma Belotserkovskaya; Julia Coates; Sophie Polo; Kyle M Miller; Stephen P Jackson
Journal:  Nature       Date:  2009-12-17       Impact factor: 49.962

10.  Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.

Authors:  Caroline Vance; Boris Rogelj; Tibor Hortobágyi; Kurt J De Vos; Agnes Lumi Nishimura; Jemeen Sreedharan; Xun Hu; Bradley Smith; Deborah Ruddy; Paul Wright; Jeban Ganesalingam; Kelly L Williams; Vineeta Tripathi; Safa Al-Saraj; Ammar Al-Chalabi; P Nigel Leigh; Ian P Blair; Garth Nicholson; Jackie de Belleroche; Jean-Marc Gallo; Christopher C Miller; Christopher E Shaw
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

View more
  111 in total

Review 1.  Relation Between Stress Granules and Cytoplasmic Protein Aggregates Linked to Neurodegenerative Diseases.

Authors:  Ioana Dobra; Serhii Pankivskyi; Anastasiia Samsonova; David Pastre; Loic Hamon
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-08       Impact factor: 5.081

Review 2.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

3.  p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.

Authors:  C J Blume; A Hotz-Wagenblatt; J Hüllein; L Sellner; A Jethwa; T Stolz; M Slabicki; K Lee; A Sharathchandra; A Benner; S Dietrich; C C Oakes; P Dreger; D te Raa; A P Kater; A Jauch; O Merkel; M Oren; T Hielscher; T Zenz
Journal:  Leukemia       Date:  2015-05-14       Impact factor: 11.528

4.  Self-assembled FUS binds active chromatin and regulates gene transcription.

Authors:  Liuqing Yang; Jozsef Gal; Jing Chen; Haining Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

5.  A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors.

Authors:  Lior Izhar; Britt Adamson; Alberto Ciccia; Jedd Lewis; Laura Pontano-Vaites; Yumei Leng; Anthony C Liang; Thomas F Westbrook; J Wade Harper; Stephen J Elledge
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

6.  RNA-binding protein RBM14 regulates dissociation and association of non-homologous end joining proteins.

Authors:  Nicholas E Simon; Ming Yuan; Mihoko Kai
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

7.  Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage.

Authors:  Sarah J Hill; Daniel A Mordes; Lisa A Cameron; Donna S Neuberg; Serena Landini; Kevin Eggan; David M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 8.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

Review 9.  Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Zongbing Hao; Rui Wang; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2020-08-29       Impact factor: 5.203

10.  Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.

Authors:  Marisa Kamelgarn; Jing Chen; Lisha Kuang; Alexandra Arenas; Jianjun Zhai; Haining Zhu; Jozsef Gal
Journal:  Biochim Biophys Acta       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.